Page last updated: 2024-11-03

probenecid and Allergic Encephalomyelitis

probenecid has been researched along with Allergic Encephalomyelitis in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research Excerpts

ExcerptRelevanceReference
"Probenecid treatment resulted in lower disease scores as compared to EAE animals."5.43Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis. ( Hainz, N; Meier, C; Tschernig, T; Wolf, S, 2016)
"Probenecid treatment resulted in lower disease scores as compared to EAE animals."1.43Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis. ( Hainz, N; Meier, C; Tschernig, T; Wolf, S, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hainz, N1
Wolf, S1
Tschernig, T1
Meier, C1

Other Studies

1 other study available for probenecid and Allergic Encephalomyelitis

ArticleYear
Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Inflammation, 2016, Volume: 39, Issue:1

    Topics: Adjuvants, Pharmaceutic; Animals; Central Nervous System; Connexins; Disease Models, Animal; Encepha

2016